Five Towns Neuroscience Research

Cedarhurst, New York 11516

0 studies enrolling now · 10 studies all time

What they study most

Alzheimer's Disease, Back Pain Lower Back Chronic, Chronic Pain, Drug Resistant Partial Onset Seizure, Epilepsy, Epilepsy With Simple or Complex Partial Onset Seizures, Heart Disease, Ischemic Heart Disease, Myocardial Infarction, Partial Epilepsy, Refractory Partial Onset Seizures, Stroke

Studies at this site

• Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension — Completed
• Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain — Completed
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures — Stopped early
• Eslicarbazepine Acetate Monotherapy Long Term Study — Completed
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs — Completed
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain — Completed